Social determinants of health and patient reported outcomes in lung cancer survivors.

person Yanmei Peng Mayo Clinic, Scottsdale, AZ info_outline Yanmei Peng, Andrea L. Cheville, Jennifer Ridgeway, Roberto P. Benzo, Jason A. Wampfler, Claire I. Yee, Matthew Buras, Nathan Y Yu, Vinicius Ernani, Pedro A Reck dos Santos, Karen L. Swanson, Jonathan D'Cunha, Aminah Jatoi, Ping Yang

Authors person Yanmei Peng Mayo Clinic, Scottsdale, AZ info_outline Yanmei Peng, Andrea L. Cheville, Jennifer Ridgeway, Roberto P. Benzo, Jason A. Wampfler, Claire I. Yee, Matthew Buras, Nathan Y Yu, Vinicius Ernani, Pedro A Reck dos Santos, Karen L. Swanson, Jonathan D'Cunha, Aminah Jatoi, Ping Yang Organizations Mayo Clinic, Scottsdale, AZ, Mayo Clinic Department of Pediatric and Adolescent Medicine, Rochester, MN, Mayo Clinic, Rochester, MN, Department of Internal Medicine, Rochester, MN, Department of Quantitative Health Sciences, Mayo Clinic Arizona, Phoenix, AZ, Mayo Clinic Arizona Department of Statistics, Scottsdale, AZ, Mayo Clinic, Phoenix, AZ Abstract Disclosures Research Funding No funding sources reported Background: Lung cancer survivors experience more physical and mental challenges, heavier symptom burden, and poorer quality of life than survivors of other cancers. Many symptoms persist or worsen for survivors beyond 5 years of cancer diagnosis, referred as long-term lung cancer survivors (LTLCS). Social determinants of health (SDoH) factors negatively impact patient reported outcomes (PROs) among cancer survivors, but their role in outcomes is under reported in lung cancer survivors and unknown in LTLCS. We investigated the impact of SDoH on PROs in a 20-year prospective lung cancer cohort. Methods: Our cohort includes 19,251 lung cancer patients (cases) diagnosed from 1997 through 2016 and followed up to 27 years, of whom 4799 (25%) became LTLCS. SDoH information was obtained by a lung cancer study PRO questionnaire or an institution SDoH questionnaire. Analyzed in this report are 2982 cases and 480 controls who had a low-dose chest CT scan and were ruled out for cancer, all answered at least one PRO questionnaire (first response); and 1366 LTLCS answered 5 years after diagnosis (long-term response). Along with fatigue and dyspnea, 5 SDoH variables, i.e., financial concerns, legal concerns, family and friends support, spiritual well-being, and social activity were scored on a 0 (worst) - 10 (best) scale and dichotomized as 0-5 (deficit/worse/lower) or 6-10 (no deficit/better/higher). We also assessed employment and health-related work experience. A difference of 1.0 unit or more in score was considered clinically meaningful along with a 2-sided test P-value less than 0.05; Chi-square or Fisher’s Exact Test and Kruskal-Wallis test were used accordingly. Results: Compared to controls, cases were younger (mean age: 62 vs. 65 years, P<0.05); more women than men reported worse financial concerns (56% vs. 38%, P<0.01) and lower spiritual well-being (43% vs. 26%, P=0.04) at first response; this sex disparity reduced but remained significant at long-term. Worse dyspnea (4.4-4.8 vs. 5.6) and fatigue (4.7-4.8 vs. 5.8-5.9) were seen in cases with more financial and legal concerns compared to those with fewer concerns (Ps<0.01). Cases with higher family and friends support, spiritual well-being and social activity had less dyspnea (5.7-6.0 vs. 4.2-4.5) and fatigue (5.5-5.9 vs. 3.9-4.4) than those with lower scores (Ps<0.04). Employment and health-related work experience data were provided by 2213 responders: Comparing 1735 cases to 478 controls, a lower proportion of cases was employed (28% vs. 39%), more cases “often felt tired after work” (49% vs. 28%), and more cases had “quite a lot” of difficulty in daily work or could not work at all” (26% vs. 9%, Ps<0.01). Conclusions: We found that in lung cancer survivors, more women than men reported worse financial concerns, and lower SDoH status was correlated with worse dyspnea and fatigue, indicating SDoH-driven interventions are important to improve lung cancer survivors’ PROs.